CAR T-Cell Therapy under FDA investigation for potential link to rare T-Cell lymphoma. Experts weigh in on risks and benefits of groundbreaking cancer treatment.
Revolutionize gene editing and diagnostics with the discovery of thousands of rare CRISPR systems. A breakthrough in molecular biology with far-reaching implications.
The FDA grants RMAT designation to Editas Medicine's EDIT-301 for severe sickle cell disease. Learn about the potential life-changing benefits of this innovative gene editing medicine.
Discover a breakthrough in xenotransplantation as pig kidneys show promising results in human patients, offering hope for the organ shortage crisis. Learn more!
Discover the groundbreaking breakthrough in pig kidney transplants, offering hope for the organ shortage crisis and a potential cure for end-stage kidney disease.
The FDA grants RMAT designation to Editas Medicine's EDIT-301 for severe sickle cell disease. Learn about the potential life-changing benefits of this innovative gene editing medicine.